C36H52BClN8O4 — CID 160819198
4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine (PubChem CID 160819198) has the molecular formula C36H52BClN8O4 and a molecular weight of 707.13 g/mol. Its IUPAC name is 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine.
| Compound Name | 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine |
|---|---|
| PubChem CID | 160819198 |
| Molecular Formula | C36H52BClN8O4 |
| Molecular Weight | 707.13 g/mol |
| Exact Mass | 706.39 |
| IUPAC Name | 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine |
| SMILES | CC1COCCN1CCCn1cc(-c2cnc3ccc(Cl)nc3c2)cn1.CC1COCCN1CCCn1cc(B2OC(C)(C)C(C)(C)O2)cn1 |
| InChI | InChI=1S/C19H22ClN5O.C17H30BN3O3/c1-14-13-26-8-7-24(14)5-2-6-25-12-16(11-22-25)15-9-18-17(21-10-15)3-4-19(20)23-18;1-14-13-22-10-9-20(14)7-6-8-21-12-15(11-19-21)18-23-16(2,3)17(4,5)24-18/h3-4,9-12,14H,2,5-8,13H2,1H3;11-12,14H,6-10,13H2,1-5H3 |
| InChIKey | SFHRZDHOVYJHLL-UHFFFAOYSA-N |
| XLogP | 4.55 |
| TPSA | 104.82 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 50 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 707.13 |
| LogP ≤ 5 | 4.55 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|